Literature DB >> 2886763

High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis.

E Adam, J L Melnick, J L Probtsfield, B L Petrie, J Burek, K R Bailey, C H McCollum, M E DeBakey.   

Abstract

157 caucasian male patients undergoing vascular surgery for atherosclerosis and a matched control group of patients with high cholesterol levels were screened for antibodies to cytomegalovirus (CMV) and herpes simplex virus type 1 (HSV1) and type 2 (HSV2), indicative of persistent infection. The prevalence of CMV antibodies was higher in the surgical group than in the control group (90% and 74%, respectively), and a significantly greater percentage (p less than 0.001) of surgical cases than controls had high titres of CMV antibodies (57% and 26%, respectively). Small but not significant differences in antibodies to HSV1 were observed, and there were no differences in HSV2 antibody titres. For each virus there was no correlation between antibody titre and blood levels of total cholesterol or triglycerides. It is suggested that periodically activated virus may have a role in the pathogenesis of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2886763     DOI: 10.1016/s0140-6736(87)90888-9

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  44 in total

1.  Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study.

Authors:  D P Strachan; D Carrington; M A Mendall; B K Butland; P M Sweetnam; P C Elwood
Journal:  Heart       Date:  1999-03       Impact factor: 5.994

Review 2.  Microorganisms in the aetiology of atherosclerosis.

Authors:  S A Morré; W Stooker; W K Lagrand; A J van den Brule; H W Niessen
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

Review 3.  Human cytomegalovirus infection and atherothrombosis.

Authors:  Milan Popović; Katarina Smiljanić; Branislava Dobutović; Tatiana Syrovets; Thomas Simmet; Esma R Isenović
Journal:  J Thromb Thrombolysis       Date:  2012-02       Impact factor: 2.300

4.  Immortalization of primary human smooth muscle cells.

Authors:  N Perez-Reyes; C L Halbert; P P Smith; E P Benditt; J K McDougall
Journal:  Proc Natl Acad Sci U S A       Date:  1992-02-15       Impact factor: 11.205

5.  The incidence of infectious diseases and changes in the mortality of atherosclerosis-related complications in the Czech population over the past two decades.

Authors:  Alena Dvorakova; Rudolf Poledne
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

6.  Cytomegalovirus infection and coronary heart disease risk: a meta-analysis.

Authors:  Ya-Nan Ji; Li An; Ping Zhan; Xiao-Hu Chen
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

Review 7.  Hepatitis C virus and metabolic disorder interactions towards liver damage and atherosclerosis.

Authors:  Umberto Vespasiani-Gentilucci; Paolo Gallo; Antonio De Vincentis; Giovanni Galati; Antonio Picardi
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

8.  Envelope glycoprotein of avian hemangioma retrovirus induces a thrombogenic surface on human and bovine endothelial cells.

Authors:  N Resnick-Roguel; A Eldor; H Burstein; E Hy-Am; I Vlodavsky; A Panet; M A Blajchman; M Kotler
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

Review 9.  Warner-Lambert/Parke-Davis Award Lecture. Viral pathogenesis of atherosclerosis. Impact of molecular mimicry and viral genes.

Authors:  D P Hajjar
Journal:  Am J Pathol       Date:  1991-12       Impact factor: 4.307

10.  Human cytomegalovirus induces monocyte differentiation and migration as a strategy for dissemination and persistence.

Authors:  M Shane Smith; Gretchen L Bentz; J Steven Alexander; Andrew D Yurochko
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.